Lymphopenia Combined With Low TCR Diversity (Divpenia) Predicts Poor Overall Survival in Metastatic Breast Cancer Patients

OncoImmunology - United States
doi 10.4161/onci.19545
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2011English

Circulating Inflammation Signature Predicts Overall Survival and Relapse-Free Survival in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Low Expression of TFPI-2 Associated With Poor Survival Outcome in Patients With Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Disease-Free Survival in Patients With Non-Metastatic Breast Cancer

Revista da Associacao Medica Brasileira
Medicine
2016English

A Seven-Gene Signature Predicts Overall Survival of Patients With Colorectal Cancer

Oncotarget
Oncology
2016English

ADAM23 Hypermethylation Predicts Decreased Disease-Free Survival in Low-Risk Breast Cancer Patients

Cancer Science
Cancer ResearchMedicineOncology
2019English

High Expression of lncRNA PVT1 Independently Predicts Poor Overall Survival in Patients With Primary Uveal Melanoma

PLoS ONE
Multidisciplinary
2017English

Pre-Operative Hypoalbuminaemia Predicts Poor Overall Survival in Rectal Cancer: A Retrospective Cohort Analysis

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy